Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis

Truncating mutations in PRNP have been associated with heterogeneous phenotypes ranging from chronic diarrhea and neuropathy to dementia, either rapidly or slowly progressive. We identified novel PRNP stop‐codon mutations (p.Y163X, p.Y169X) in two Italian kindreds. Disease typically presented in the third or fourth decade with progressive autonomic failure and diarrhea. Moreover, one proband (p.Y163X) developed late cognitive decline, whereas some of his relatives presented with isolated cognitive and psychiatric symptoms. Our results strengthen the link between PRNP truncating mutations and systemic abnormal PrP deposition and support a wider application of PRNP screening to include unsolved cases of familial autonomic neuropathy.

[1]  B. Caughey,et al.  High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions , 2017, Scientific Reports.

[2]  A. Green,et al.  Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels , 2017, Acta Neuropathologica.

[3]  K. Rankin,et al.  Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy. , 2016, Journal of Alzheimer's disease : JAD.

[4]  S. Mead,et al.  A new prion disease: relationship with central and peripheral amyloidoses , 2015, Nature Reviews Neurology.

[5]  J. Hardy,et al.  A nonsense mutation in PRNP associated with clinical Alzheimer's disease , 2014, Neurobiology of Aging.

[6]  A. Forbes,et al.  A novel prion disease associated with diarrhea and autonomic neuropathy. , 2013, The New England journal of medicine.

[7]  K. Abe,et al.  A novel familial prion disease causing pan‐autonomic‐sensory neuropathy and cognitive impairment , 2013, European journal of neurology.

[8]  P. Cortelli,et al.  Peripheral Autonomic Neuropathy: Diagnostic Contribution of Skin Biopsy , 2012, Journal of neuropathology and experimental neurology.

[9]  Piero Parchi,et al.  Molecular pathology, classification, and diagnosis of sporadic human prion disease variants. , 2012, Folia neuropathologica.

[10]  G. Schellenberg,et al.  Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype , 2011, Annals of neurology.

[11]  F. Baas,et al.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP , 2009, Acta Neuropathologica.

[12]  G. Plant,et al.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.

[13]  E. Masliah,et al.  Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice , 2006, Science.

[14]  B. Ghetti,et al.  Hereditary prion protein amyloidoses. , 2003, Clinics in laboratory medicine.

[15]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[16]  H. Budka,et al.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Buxbaum,et al.  The systemic amyloidoses. , 1998, The New England journal of medicine.

[18]  B. Ghetti,et al.  Prion Protein Amyloidosis , 1996, Brain pathology.

[19]  T. Kitamoto,et al.  An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. , 1993, Biochemical and biophysical research communications.

[20]  S. Prusiner,et al.  Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. , 1990, Biochemistry.